EUVIMEDEUVIMED entdecken
Crossref

Pharmacological and Biological Tools to Inhibit IP 3 Receptors

Robbe Van Gorp, Tihomir Tomašič, Jan B Parys, Martin D Bootman, Geert Bultynck

Cold Spring Harbor Perspectives in Biology · 27.04.2026 · a041771

DOI: 10.1101/cshperspect.a041771 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cold Spring Harbor Perspectives in Biology, online erschienen am 27.04.2026. Verfasst von Robbe Van Gorp und 4 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Molecular and Cellular Signaling, Department of Cellular and Molecular Medicine, KU Leuven, 3000 Leuven, Belgium.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Inositol 1,4,5-trisphosphate receptors (IP3Rs) are an important class of ion channels that mediate calcium (Ca2+) release from the endoplasmic reticulum and other organelles, thereby critically controlling cell function. Dysregulation of these channels, including excessive IP3R activity, has been implicated in a plethora of diseases. The current arsenal of tools to acutely inhibit IP3Rs consists of various antagonists with distinct mechanisms of action. Yet, most suffer from limited selectivity due to their impact on several other Ca2+-transport systems, cellular targets, and/or lack of membrane permeability. This shortage of highly specific IP3R antagonists limits biomedical research and hampers the development of therapeutic strategies targeting IP3R channels. This work aims to provide a comprehensive overview of IP3R-antagonizing tools that were developed and characterized over the past decades, focusing on three classes of molecules: (1) pharmacological antagonists that directly affect IP3Rs by binding to the channel, (2) biological antagonists that directly affect IP3Rs by interacting with the IP3R, and (3) antagonism of IP3R activity via regulation of the phosphoinositide signaling pathway upstream of IP3Rs.

Autor:innen und Institutionen

  • Laboratory of Molecular and Cellular Signaling, Department of Cellular and Molecular Medicine, KU Leuven, 3000 Leuven, Belgium.
  • Department of Pharmaceutical Chemistry, Faculty of Pharmacy, University of Ljubljana, 1000 Ljubljana, Slovenia.
  • School of Life, Health and Chemical Sciences, The Open University, Milton Keynes MK7 6AA, United Kingdom.
  • Laboratory of Molecular and Cellular Signaling, Department of Cellular and Molecular Medicine, KU Leuven, 3000 Leuven, Belgium geert.bultynck@kuleuven.be.

Zitieren

APA

Van Gorp, R., Tomašič, T., Parys, J. B., Bootman, M. D., & Bultynck, G. (2026). Pharmacological and Biological Tools to Inhibit IP 3 Receptors. Cold Spring Harbor Perspectives in Biology, a041771. https://doi.org/10.1101/cshperspect.a041771

Vancouver

Van Gorp R, Tomašič T, Parys JB, Bootman MD, Bultynck G. Pharmacological and Biological Tools to Inhibit IP 3 Receptors. Cold Spring Harbor Perspectives in Biology. 2026:a041771. doi:10.1101/cshperspect.a041771

BibTeX
@article{VanGorp2026,
  author = {Van Gorp, Robbe and Tomašič, Tihomir and Parys, Jan B and Bootman, Martin D and Bultynck, Geert},
  title = {Pharmacological and Biological Tools to Inhibit IP 3 Receptors},
  journal = {Cold Spring Harbor Perspectives in Biology},
  year = {2026},
  pages = {a041771},
  doi = {10.1101/cshperspect.a041771}
}
Kostenlos starten →